Literature DB >> 15353870

Comparison of rate and rhythm control in patients with atrial fibrillation and nonischemic heart failure.

Bariş Okçün1, Zerrin Yigit, Alev Arat, Serdar M Küçükoglu.   

Abstract

Atrial fibrillation (AF) is a very common cardiac arrhythmia with an increased mortality in patients with heart failure. Whether the best therapeutic approach to these patients is to restore sinus rhythm or to adequately control the ventricular rate is still controversial. The aim of this study was to compare both strategies in patients with AF and nonischemic heart failure. One hundred and fifty-four patients with AF duration greater than 48 hours and nonischemic left ventricular dysfunction were randomized either to a rhythm (n = 84) or rate (n = 74) control group. The composite end points of the study were embolism, death, and exercise capacity. The average age of the patients was 61 +/- 10 years in the rhythm control group and 58 +/- 12 years in the rate control group (P = NS). The average follow-up period was 35 +/- 21 months in the rhythm control group and 37 +/- 19 months in the rate control group (P = NS). In the first year of the study, exercise capacity and left ventricular ejection fraction (LVEF) were improved in the rhythm control group compared to the exercise capacity and LVEF of the rate control group (P < 0.0001 and P = 0.0005, respectively). There were no statistically significant differences in the embolic event rate between the two groups (P = NS). The mortality rate, especially for death due to pump failure, was significantly higher in the rate control group at the end of the study (P < 0.0001). Restoring and maintaining sinus rhythm had a beneficial effect on mortality and exercise capacity in patients with nonischemic heart failure and AF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353870     DOI: 10.1536/jhj.45.591

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  8 in total

Review 1.  Atrial fibrillation (chronic).

Authors:  Deirdre A Lane; Stavros Apostolakis; Christopher J Boos; Gregory Y H Lip
Journal:  BMJ Clin Evid       Date:  2011-11-10

Review 2.  Should rhythm control be preferred in younger atrial fibrillation patients?

Authors:  Shaojie Chen; Yuehui Yin; Mitchell W Krucoff
Journal:  J Interv Card Electrophysiol       Date:  2012-05-22       Impact factor: 1.900

Review 3.  Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Virginia Mplani; Maria Anastasopoulou; Nicholas Kounis; Cesare de Gregorio; Grigorios Tsigkas; Arun Karunakaran; Panagiotis Plotas; Ignatios Ikonomidis
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

4.  Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Dibbendhu Khanra; Saurabh Deshpande; Anindya Mukherjee; Siddhratha Mohan; Hassan Khan; Sanjeev Kathuria; Danesh Kella; Deepak Padmanabhan
Journal:  Int J Heart Fail       Date:  2021-06-11

Review 5.  Atrial fibrillation (chronic).

Authors:  Christopher J Boos; Deirdre A Lane; Gregory Y H Lip
Journal:  BMJ Clin Evid       Date:  2008-04-30

Review 6.  Chronic Amiodarone Use and the Risk of Cancer: A Systematic Review and Meta-analysis.

Authors:  Lauren A Siemers; Jenny MacGillivray; Jason G Andrade; Ricky D Turgeon
Journal:  CJC Open       Date:  2020-09-17

Review 7.  Management of atrial fibrillation.

Authors:  Puneet Kakar; Christopher J Boos; Gregory Y H Lip
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Naqash J Sethi; Joshua Feinberg; Emil E Nielsen; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.